Risk-based early-term birth might be the key to cutting preeclampsia risk in high-risk pregnancies.
Story Overview
- Early-term births at 37 weeks for high-risk pregnancies may reduce preeclampsia by half.
- A large study in South East England examined individualized preeclampsia risk and birth timing.
- The competing-risks prediction model suggests no increase in serious neonatal complications.
- This preventive approach requires further validation in randomized trials.
Understanding Preeclampsia and Its Risks
Preeclampsia, a hypertensive disorder that impacts pregnant women after 20 weeks, remains a major cause of maternal and infant health issues. It requires careful management of pregnancy duration to balance the mother’s health risks against potential infant prematurity. Advances in screening, particularly in the UK, have led to new algorithms for detecting risk factors early in pregnancy, such as using maternal characteristics and biomarkers like PlGF, PAPP-A, and sFlt-1. These developments help predict preeclampsia risk, but until now, no strategy linked risk prediction to planned birth timing.
Recent studies have shifted focus to preeclampsia at term, recognizing the impact of improved care on shifting disease occurrence to later pregnancy stages. The effectiveness of low-dose aspirin in preventing preterm preeclampsia is known, yet no pharmacologic prevention exists for term occurrences. The study proposes that “timed birth at term” using robust risk prediction could be a powerful intervention, especially in resource-limited settings.
Free consult for hormone and fertility questions.
New Strategies to Prevent Preeclampsia
The study, conducted in South East England and involving approximately 90,000 pregnancies, utilized a competing-risks algorithm incorporating clinical and biochemical markers. It suggests that planned delivery at 37 weeks for high-risk women could prevent over 50% of term preeclampsia cases. The study found that for every eight to ten inductions, one case of preeclampsia could be prevented, without an increase in serious complications. This approach, however, isn’t standard practice yet and calls for randomized trials to confirm these findings.
While the focus is on risk-stratified planned births, the study highlights the need for a personalized timing-of-birth strategy. The competing-risks model, particularly when using PlGF-based prediction at 35-36 weeks, showed promising results in detecting and preventing term preeclampsia. Implementing delivery at 37 weeks in high-risk women could significantly reduce incidence, but careful consideration of neonatal outcomes and healthcare resources is crucial.
Watch:
https://www.youtube.com/watch?v=mG5y078GVrc
Get expert support for fertility and reproductive health.
Implications for the Future
The potential to halve term preeclampsia incidence through risk-based early-term birth holds significant promise for maternal health, especially in settings with limited resources. While short-term neonatal outcomes may include slight increases in NICU admissions, the trade-off could be favorable if severe maternal conditions are prevented. The study advocates for randomized controlled trials to solidify this strategy’s safety and effectiveness before widespread adoption.
As guidelines evolve, integrating formal risk prediction tools and precise timing-of-birth recommendations could mirror practices seen in conditions like gestational diabetes. For high-risk women, individualized birth planning might soon become a reality, reducing the burden of preeclampsia worldwide and improving both maternal and infant health outcomes.
Start your free women’s health consultation now.
Sources:
PMC Article
The Cardiology Advisor
Preeclampsia Foundation
